Pharmaceutics articles within Nature

Featured

  • Article
    | Open Access

    A tethered macrocyclic peptide antibiotic class described here—which shows potent antibacterial activity against carbapenem-resistant Acinetobacter baumannii—blocks the transport of bacterial lipopolysaccharide from the inner membrane to its destination on the outer membrane through inhibition of the LptB2FGC complex.

    • Claudia Zampaloni
    • , Patrizio Mattei
    •  & Kenneth A. Bradley

  • Review Article |

    The development and future prospects of prospectively designed multispecific drugs, which have the potential to transform the biopharmaceutical industry by enabling the targeting of currently inaccessible components of the proteome, are reviewed.

    • Raymond J. Deshaies

  • Letter |

    The discovery is reported of a small molecule drug, GS-5734, which has antiviral activity against Ebola virus and other filoviruses, and is capable of providing post-exposure therapeutic protection against lethal disease in 100% of drug-treated nonhuman primates infected with Ebola virus; the drug targets viral RNA polymerase and can distribute to sanctuary sites (such as testes, eyes and brain), suggesting that it may be able to clear persistent virus infection.

    • Travis K. Warren
    • , Robert Jordan
    •  & Sina Bavari

Browse broader subjects

Browse Pharmaceutics across other nature.com journals